Distribution of C-reactive protein and its association with cardiovascular risk factors in a population-based sample of Chinese

Disease Markers

Volumn 28, Issue 6, 2010, Pages 333-342

  Zhao, Yanfang ^a   Wang, Rui ^a   Ma, Xiuqiang ^a   Yan, Xiaoyan ^a   Zhang, Zhansai ^b   He, Xiang ^a   He, Jia ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b Health Inspection Institute of Changning District   (China)

Author keywords

C reactive protein; Cardiovascular; Chinese; Risk factors

Indexed keywords

C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CHINA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MALE; METABOLISM; MIDDLE AGED; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; BODY MASS INDEX; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CHINA; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; PROGNOSIS; RISK FACTORS; TRIGLYCERIDES; YOUNG ADULT;

EID: 78149476740     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.3233/DMA-2010-0713     Document Type: Article

References (40)

1. L.G. Futterman and L. Lemberg, Fifty percent of patients with coronary artery disease do not have any of the conventional risk factors, Am J Crit Care 7 (1998), 240-244.
2. E. Braunwald, Cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities, N Engl J Med 337 (1997), 1360-1369.
3. R. Ross, Atherosclerosis - an inflammatory disease, N Engl J Med 340 (1999), 115-126.
4. M.L. Yen, C.Y. Yang, B.L. Yen, Y.L. Ho, W.C. Cheng and C.H. Bai, Increased high sensitivity C-reactive protein and neutrophil count are related to increased standard cardiovascular risk factors in healthy Chinese men, Int J Cardiol 110 (2006), 191-198.
5. M. Miller, M. Zhan and S. Havas, High attributable risk of elevated C-reactive protein level to conventional coronary heart disease risk factors: the Third National Health and Nutrition Examination Survey, Arch Intern Med 165 (2005), 2063-2068.
6. M.H. Shishehbor, D.L. Bhatt and E.J. Topol, Using C-reactive protein to assess cardiovascular disease risk, Cleve Clin J Med 70 (2003), 634-640.
7. T.A. Pearson, G.A. Mensah, R.W. Alexander, J.L. Anderson, R.O. Cannon 3rd, M. Criqui, Y.Y. Fadl, S.P. Fortmann, Y. Hong, G.L. Myers, N. Rifai, S.C. Smith Jr, K. Taubert and R.P. Tracy, F. Vinicor; Centers for Disease Control and Prevention; American Heart Association, Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association, Circulation 107 (2003), 499-511.
8. A. Khera, D.K. McGuire, S.A. Murphy, H.G. Stanek, S.R. Das, W. Vongpatanasin, F.H.Wians, Jr., S.M. Grundy and J.A. de Lemos, Race and gender differences in C-reactive protein levels, J Am Coll Cardiol 46 (2005), 464-469.
9. A. Kelley-Hedgepeth, D.M. Lloyd-Jones, A. Colvin, K.A. Matthews, J. Johnston, M.R. Sowers, B. Sternfeld, R.C. Pasternak, C.U. Chae and SWAN Investigators, Ethnic differences in C-reactive protein concentrations, Clin Chem 54 (2008), 1027-1037.
10. K.A. Matthews, M.F. Sowers, C.A. Derby, E. Stein, H. Miracle-McMahill, S.L. Crawford and R.C. Pasternak, Ethnic differences in cardiovascular risk factor burden among middleaged women: Study of Women’s Health Across the Nation (SWAN), Am Heart J 149 (2005), 1066-1073.
11. Y.F. Wu, D. Zhao, B.F. Zhou, W. Wang, X. Li, J. Liu, Y. Li, J.Y. Sun, L.C. Zhao, Z.S. Wu and J.R. Zhu, Cut offs and risk stratification of dyslipidemia in Chinese adults, Zhonghua Xin Xue Guan Bing Za Zhi 35 (2007), 428-433.
12. Z. Bei-Fan, Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults: study on optimal cut-off points of body mass index and waist circumference in Chinese adults, Asia Pac J Clin Nutr 11 (2002), S685-S693.
13. P.M. Ridker, N. Rifai, L. Rose, J.E. Buring and N.R. Cook, Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events, N Engl J Med 347 (2002), 1557-1565.
14. T.A. Pearson, T.L. Bazzarre, S.R. Daniels, J.M. Fair, S.P. Formann, B.A. Franklin, L.B. Goldstein, Y. Hong, G.A. Mensah, J.F. Sallis Jr., S. Smith Jr., N.J. Stone, K.A. Taubert and American Heart Association Expert Panel on Population and Prevention Science, American Heart Association guide for improving cardiovascular health at the community level: a statement for public health practitioners, healthcare providers, and health policy makers from the Am Heart Association Expert Panel on Population and Prevention Science, Circulation 107 (2003), 645-651.
15. B. Yuan, H. Zhang, J. Zou and D. Wang, Distribution of Creactive protein in health adults, Lin Chuang Jian Yan Za Zhi 23 (2005), 236-237.
16. Q. Dong, D. Yang, H. Ye, J. Fang and Y. Zhang, Distributions of C-reactive Protein and Association with Lipid in 579 Healthy Volunteers, Chin J Hemor 26 (2006), 444-446.
17. X. Ye, Z. Yu, H. Li, O.H. Franco, Y. Liu and X. Lin, Distributions of C-reactive protein and its association with metabolic syndrome in middle-aged and older Chinese people, J Am Coll Cardiol 49 (2007), 1798-1805.
18. J. Sun, D. Zhao, W. Wang, J. Liu, J. Cheng, J. Liu, Y. Li and Y. Jia, Distributions of high-sensitivity C-reactive protein and its association with metabolic syndrome in population aged 45-74 in Bering, Chin J Epidemiol 28 (2007), 1155-1158.
19. Q. Bao, W. Jia, L. Chen, J. Lu and K. Xiang, Association between C-reactive protein level and metabolic syndrome and components thereof, Natl Med J China 86 (2006), 2105-2109.
20. H. Song, Expression of serum high sensitive C reactive protein in high low-density lipoprotein cholesterol patient, Chin J Med Writing 11 (2004), 561-562.
21. S. He, Y. Zhuang and L. Chen, Establishing the reference range of high-sensitivity C-reactive protein measurements in 506 healthy adults in Shenzhen area, Chin J Misdiagn 4 (2004), 836-838.
22. E.Y. Choi, E.H. Park, Y.S. Cheong, I. Rheem, S.G. Park and S. Yoo, Association of C-reactive protein with the metabolic risk factors among young and middle-aged Koreans, Metabolism 55 (2006), 415-421.
23. I. Saito, S. Sato, M. Nakamura, Y. Kokubo, T. Mannami, H. Adachi, M. Konishi, K. Okada, H. Iso, K. Kario, F. Ohsuzu, Y. Momiyama and M. Tsushima, A low level of C-reactive protein in Japanese adults and its association with cardiovascular risk factors: the Japan NCVC-Collaborative Inflammation Cohort (JNIC) study, Atherosclerosis 194 (2007), 238-244.
24. J. Hung, M.W. Knuiman, M.L. Divitini, T. Davis and J.P. Beilby, Prevalence and risk factor correlates of elevated C-reactive protein in an adult Australian population, Am J Cardiol 101 (2008), 193-198.
25. J. Danesh, J.G. Wheeler, G.M. Hirschfield, S. Eda, G. Eiriksdottir, A. Rumley, G.D. Lowe, M.B. Pepys and V. Gudnason, C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease, N Engl J Med 350 (2004), 1387-1397.
26. S. Anand S., F. Razak, Q. Yi, B. Davis, R. Jacobs, V. Vuksan, E. Lonn, K. Teo, M. McQueen and S.Yusuf, C-reactive protein as a screening test for cardiovascular risk in a multiethnic population, Arterioscler Thromb Vasc Biol 24 (2004), 1509-1515.
27. T.B. Ledue and N, Rifai, Preanalytic and analytic sources of variations in C-reactive protein measurement: implications for cardiovascular disease risk assessment, Clin Chem 49 (2003), 1258-1271.
28. A.J. MacGregor, J.R. Gallimore, T.D. Spector and M.B. Pepys, Genetic effects on baseline values of C-reactive protein and serum amyloid A protein: a comparison of monozygotic and dizygotic twins, Clin Chem 50 (2004), 130-134.
29. X. Zhang, X.O. Shu, L.B. Signorello, M.K. Hargreaves, Q. Cai, M.F. Linton, S. Fazio, W. Zheng andW.J. Blot, Correlates of high serum C-reactive protein levels in a socioeconomically disadvantaged population, Dis Markers 24 (2008), 351-359.
30. X.Q. Lao, G.N. Thomas, C.Q. Jiang, W.S. Zhang, P. Yin, P. Adab, T.H. Lam and K.K. Cheng, C-reactive protein and the metabolic syndrome in older Chinese: Guangzhou Biobank Cohort Study, Atherosclerosis 194 (2007), 483-489.
31. D. Gu, K. Reynolds, X.Wu, J. Chen, X. Duan, R.F. Reynolds, P.K. Whelton, J. He and InterASIA Collaborative Group, Prevalence of the metabolic syndrome and overweight among adults in China, Lancet 365 (2005), 1398-1405.
32. J.S. Yudkin, C.D. Stehouwer, J.J. Emeis and S.W. Coppack, C-reactive protein in healthy participants: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 19 (1999), 972-978.
33. A. Galassi, K. Reynolds and J. He, Metabolic syndrome and risk of cardiovascular disease: a meta-analysis, Am J Med 119 (2006), 812-819.
34. Y. He, B. Jiang, J.Wang, K. Feng, Q. Chang, L. Fan, X. Li and F.B. Hu, Prevalence of the metabolic syndrome and its relation to cardiovascular disease in an elderly Chinese population, J Am Coll Cardiol 47 (2006), 1588-1594.
35. S. Lim, H.K. Lee, K.C. Kimm, C. Park, C. Shin and N.H. Cho, C-reactive protein level as an independent risk factor of metabolic syndrome in the Korean population. CRP as risk factor of metabolic syndrome, Diabetes Res Clin Pract 70 (2005), 126-133.
36. E.S. Ford, W.H. Giles, A.H. Mokdad and G.L. Myers, Distribution and correlates of C-reactive protein concentrations among adult US women, Clin Chem 50 (2004), 574-581.
37. M. Raitakari, K. Mansikkaniemi, J. Marniemi, J.S.Viikari and O.T. Raitakari, Distribution and determinants of serum highsensitive C-reactive protein in a population of young adults: The Cardiovascular Risk in Young Finns Study, J Intern Med 258 (2005), 428-434.
38. M.A. Martí(dotless)nez, J.G. Puig, M. Mora, R. Aragón, P. O’Dogherty, J.L. Antón, T. Sánchez-Villares, J.M. Rubio, J. Rosado, R. Torres, J. Marcos, L.F. Pallardo, J.R. Banegas and MAPA (Monitorización Ambulatoria de la Presión Arterial) Working Group, Metabolic syndrome: prevalence, associated factors, and C-reactive protein: the MADRIC (MADrid RIesgo Cardiovascular) Study, Metabolism 57 (2008), 1232-1240.
39. R. Arena, J.A. Arrowood, D.Y. Fei, S. Helm and K.A. Kraft, The relationship between C-reactive protein and other cardiovascular risk factors in men and women, J Cardiopulm Rehabil 26 (2006), 323-327.
40. J. O’Loughlin, M. Lambert, I. Karp, J. McGrath, K. Gray-Donald, T.A. Barnett, E.E. Delvin, E. Levy and G. Paradis, Association between cigarette smoking and C-reactive protein in a representative, population-based sample of adolescents, Nicotine Tob Res 10 (2008), 525-532.